These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 36232866)
1. Archaea Microbiome Dysregulated Genes and Pathways as Molecular Targets for Lung Adenocarcinoma and Squamous Cell Carcinoma. Uzelac M; Li Y; Chakladar J; Li WT; Ongkeko WM Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232866 [TBL] [Abstract][Full Text] [Related]
2. System analysis of Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116 [TBL] [Abstract][Full Text] [Related]
3. Intratumoral Microbiota-Host Interactions Shape the Variability of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma in Recurrence and Metastasis. Zhou X; Ji L; Ma Y; Tian G; Lv K; Yang J Microbiol Spectr; 2023 Jun; 11(3):e0373822. PubMed ID: 37074188 [TBL] [Abstract][Full Text] [Related]
4. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma. Yang Y; Wang M; Liu B J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601 [TBL] [Abstract][Full Text] [Related]
5. Smoking is Associated with Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Progression through Inducing Distinguishing lncRNA Alterations in Different Genders. Liu B; Liu Y; Zou J; Zou M; Cheng Z Anticancer Agents Med Chem; 2022; 22(8):1541-1550. PubMed ID: 34315392 [TBL] [Abstract][Full Text] [Related]
6. Differential prognostic impact and potential molecular mechanisms of PCDHGA12 expression in lung adenocarcinoma and squamous cell carcinoma. Xu X; Zhang J; Yao T; Zhao X; Wu Q; Lu C; Guo X; Xie S; Qiu L; Bi R; Xue H Int Immunopharmacol; 2024 Sep; 139():112727. PubMed ID: 39067405 [TBL] [Abstract][Full Text] [Related]
7. Common and distinct patterns of acquired uniparental disomy and homozygous deletions between lung squamous cell carcinomas and lung adenocarcinoma. Tuna M; Mills GB; Amos CI Neoplasia; 2023 Nov; 45():100932. PubMed ID: 37801862 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer. Yu H; Pang Z; Li G; Gu T J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722 [TBL] [Abstract][Full Text] [Related]
9. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma. Liu B; Chen Y; Yang J Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974 [TBL] [Abstract][Full Text] [Related]
10. [Identification of differentially expressed genes between lung adenocarcinoma and squamous cell carcinoma using transcriber signature analysis]. Peng S; Li X; Liu Q; Zhang Y; Zou L; Gong X; Wang M; Ma X Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jun; 39(6):641-649. PubMed ID: 31270041 [TBL] [Abstract][Full Text] [Related]
11. GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma. Ning J; Jiang S; Li X; Wang Y; Deng X; Zhang Z; He L; Wang D; Jiang Y BMC Pulm Med; 2021 Jun; 21(1):199. PubMed ID: 34112123 [TBL] [Abstract][Full Text] [Related]
12. Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma. Yin D; Zhang Y; Li H; Cheng L Clin Respir J; 2023 Dec; 17(12):1301-1315. PubMed ID: 37985446 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Dong R; Liu J; Sun W; Ping W Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis. Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Zengin T; Önal-Süzek T J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33672117 [TBL] [Abstract][Full Text] [Related]
16. Ferroptosis-Related Genes Are Potential Therapeutic Targets and the Model of These Genes Influences Overall Survival of NSCLC Patients. Zhang N; Wu Y; Wu Y; Wang L; Chen J; Wang X; Chard Dunmall LS; Cheng Z; Wang Y Cells; 2022 Jul; 11(14):. PubMed ID: 35883650 [TBL] [Abstract][Full Text] [Related]
17. ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma. Hou G; Lu Z; Bi Y; Deng J; Yang X Med Oncol; 2022 Feb; 39(5):51. PubMed ID: 35150321 [TBL] [Abstract][Full Text] [Related]
18. What's the difference between lung adenocarcinoma and lung squamous cell carcinoma? Evidence from a retrospective analysis in a cohort of Chinese patients. Wang W; Liu H; Li G Front Endocrinol (Lausanne); 2022; 13():947443. PubMed ID: 36105402 [TBL] [Abstract][Full Text] [Related]
19. The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates. Meng F; Zhang L; Ren Y; Ma Q J Cell Physiol; 2019 Jul; 234(7):10918-10925. PubMed ID: 30549039 [TBL] [Abstract][Full Text] [Related]
20. Blood FOLR3 methylation dysregulations and heterogeneity in non-small lung cancer highlight its strong associations with lung squamous carcinoma. Qu Y; Zhang X; Qiao R; Di F; Song Y; Wang J; Ji L; Zhang J; Gu W; Fang Y; Han B; Yang R; Dai L; Ouyang S Respir Res; 2024 Jan; 25(1):59. PubMed ID: 38273401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]